Published online Dec 28, 2017. doi: 10.3748/wjg.v23.i48.8443
Peer-review started: May 5, 2017
First decision: June 7, 2017
Revised: June 19, 2017
Accepted: July 12, 2017
Article in press: July 12, 2017
Published online: December 28, 2017
Processing time: 237 Days and 20.1 Hours
Ischaemia-reperfusion injury (IRI) is the leading cause of injury seen in the liver following transplantation. IRI also causes injury following liver surgery and haemodynamic shock. The first cells within the liver to be injured by IRI are the liver sinusoidal endothelial cells (LSEC). Recent evidence suggests that LSEC co-ordinate and regulates the livers response to a variety of injuries. It is becoming increasingly apparent that the cyto-protective cellular process of autophagy is a key regulator of IRI. In particular LSEC autophagy may be an essential gatekeeper to the development of IRI. The recent availability of liver perfusion devices has allowed for the therapeutic targeting of autophagy to reduce IRI. In particular normothermic machine liver perfusion (NMP-L) allow the delivery of pharmacological agents to donor livers whilst maintaining physiological temperature and hepatic flow rates. In this review we summarise the current understanding of endothelial autophagy and how this may be manipulated during NMP-L to reduce liver IRI.
Core tip: Liver sinusoidal endothelial cells autophagy regulates liver ischaemia reperfusion injury and this process can be targeted for therapeutic benefit using normothermic machine liver perfusion.
